IMMUNOGENICITY OF SINGLE COMPARED TO TWO-DOSE PRIMARY SERIES FOLLOWED BY BOOSTER DOSE OF 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE (PCV) IN SOUTH AFRICA: OPEN-LABEL, RANDOMISED, NON-INFERIORITY TRIAL (ID 1153)

Session Name
Vaccines - Pneumococcal Vaccines Development
Presenter
  • Shabir A. Madhi, South Africa
Authors
  • Shabir A. Madhi, South Africa
  • Eleonora Mutsaerts,
  • Alane Izu,
  • Welekazi Boyce,
  • Sutika Bhikha,
  • Benit Ikulinda,
  • Lisa Jose,
  • Anthonet Koen,
  • Amit Nana,
  • Andrew Moultrie,
  • Lucy Roalfe, United Kingdom
  • Adam Hunt,
  • David Goldblatt, United Kingdom
  • Clare L. Cutland,
  • Jeffrey R. Dorfman,